Elstner with colleagues proposed promising serum protein profile, consisting of BMP2, HSP70, and CXCL10 (IP-10), which was able to distinguish GBM group with the specificity and sensitivity of 89% and 96% from control one, respectively25. The gene discussed is CXCL10; the disease is glioblastoma.